TY - JOUR
T1 - Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen
AU - Haluska, Paul
AU - Saleem, Ahamed
AU - Edwards, Troy K.
AU - Rubin, Eric H.
N1 - Funding Information:
The authors would like to thank Dr Steven J.Brill for providing purified T antigen and Drs Leroy F.Liu, Marc R.Gartenberg and Nancy C.Walworth for helpful comments regarding this work. This investigation was supported by United States Public Health Service Grant CA70981, awarded by the National Cancer Institute.
PY - 1998/4/1
Y1 - 1998/4/1
N2 - We have attempted to identify human topoisomerase I-binding proteins in order to gain information regarding the cellular roles of this protein and the cytotoxic mechanisms of the anticancer drug camptothecin, which specifically targets topoisomerase I. In the course of this work we identified an interaction between the N-terminus of human topoisomerase I and the SV40 T antigen that is detectable in vitro using both affinity chromatography and co-immunoprecipitation. Additional results indicate that this interaction does not require intermediary DNA or stoichiometric quantities of other proteins. Furthermore, the interaction is detectable in vivo using a yeast two-hybrid assay. Two binding sites for T antigen are apparent on the topoisomerase I protein: one consisting of amino acids 1-139, the other present in the 383-765 region of the protein. Interestingly, nucleolin, which binds the 166-210 region of topoisomerase I, is able to bind an N-terminal fragment of topoisomerase I concurrently with T antigen. Taken together with our prior identification of nucleolin as a topoisomerase I-binding protein, the current results suggest that helicase-binding is a major role of the N-terminus of human topoisomerase I and that the resultant helicase-topoisomerase complex may function as a eukaryotic gyrase.
AB - We have attempted to identify human topoisomerase I-binding proteins in order to gain information regarding the cellular roles of this protein and the cytotoxic mechanisms of the anticancer drug camptothecin, which specifically targets topoisomerase I. In the course of this work we identified an interaction between the N-terminus of human topoisomerase I and the SV40 T antigen that is detectable in vitro using both affinity chromatography and co-immunoprecipitation. Additional results indicate that this interaction does not require intermediary DNA or stoichiometric quantities of other proteins. Furthermore, the interaction is detectable in vivo using a yeast two-hybrid assay. Two binding sites for T antigen are apparent on the topoisomerase I protein: one consisting of amino acids 1-139, the other present in the 383-765 region of the protein. Interestingly, nucleolin, which binds the 166-210 region of topoisomerase I, is able to bind an N-terminal fragment of topoisomerase I concurrently with T antigen. Taken together with our prior identification of nucleolin as a topoisomerase I-binding protein, the current results suggest that helicase-binding is a major role of the N-terminus of human topoisomerase I and that the resultant helicase-topoisomerase complex may function as a eukaryotic gyrase.
UR - http://www.scopus.com/inward/record.url?scp=2642694700&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2642694700&partnerID=8YFLogxK
U2 - 10.1093/nar/26.7.1841
DO - 10.1093/nar/26.7.1841
M3 - Article
C2 - 9512561
AN - SCOPUS:2642694700
SN - 0305-1048
VL - 26
SP - 1841
EP - 1847
JO - Nucleic Acids Research
JF - Nucleic Acids Research
IS - 7
ER -